Table 3.
Univariate and adjusted logistic regression models assessing factors associated with lower 12-month total atrial fibrillation management after catheter ablation
| Characteristics | Unadjusted odds ratio (95% CI) | Adjusted odds ratio (95% CI) |
|---|---|---|
| AF type (paroxysmal vs persistent) | 1.103 (0.974–1.248) | 1.133 (0.995–1.290) |
| Age | ||
| 19–49 years | 1.435 (1.049–1.963)∗ | 1.194 (0.830–1.717) |
| 50–59 years | 1.478 (1.220–1.790)∗ | 1.261 (0.984–1.616) |
| 60–69 years | 1.186 (1.031–1.363)∗ | 1.108 (0.946–1.297) |
| ≥70 years | REF | REF |
| Sex (male vs female) | 1.025 (0.906–1.161) | 0.964 (0.836–1.110) |
| Region | ||
| Midwest | REF | REF |
| Northeast | 1.070 (0.867–1.321) | 1.126 (0.908–1.398) |
| South | 0.906 (0.780–1.053) | 0.940 (0.805–1.097) |
| West | 0.929 (0.760–1.136) | 0.977 (0.796–1.200) |
| Unknown | 1.825 (0.204–16.362) | 2.652 (0.290–24.287) |
| Insurance type | ||
| EPO / HMO | REF | REF |
| Indemnity | 0.732 (0.373–1.438)∗ | 0.860 (0.432–1.712) |
| Point of Service/Preferred Provider Organization | 0.945 (0.754–1.186)∗ | 0.959 (0.760–1.210) |
| Other | 0.698 (0.566–0.862)∗ | 0.768 (0.612–0.965)∗ |
| Hospital bed size | ||
| Large | REF | REF |
| Medium | 0.925 (0.770–1.111) | 0.967 (0.802–1.167) |
| Small | 1.061 (0.644–1.746) | 1.021 (0.616–1.694) |
| Unknown | 1.031 (0.889–1.196) | 1.026 (0.881–1.195) |
| Admission year | ||
| 2016 | REF | REF |
| 2017 | 0.875 (0.705–1.085) | 0.900 (0.723–1.120) |
| 2018 | 0.859 (0.687–1.074) | 0.893 (0.711–1.122) |
| CHA2DS2-VASc score | ||
| 0 | REF | REF |
| 1 and 2 | 0.914 (0.661–1.263) | 0.935 (0.638–1.368) |
| 3 and above | 0.822 (0.602–1.123) | 0.925 (0.585–1.462) |
| CCI score | ||
| 0 | REF | REF |
| 1 and 2 | 1.057 (0.905–1.233) | 1.103 (0.916–1.328) |
| 3 and above | 0.984 (0.838–1.157) | 1.131 (0.868–1.475) |
| ICD/CRT-D | 0.984 (0.789–1.226) | 0.928 (0.731–1.177) |
| Sleep apnea | 1.160 (1.022–1.318)∗ | 1.096 (0.953–1.260) |
| Obesity | 1.245 (1.089–1.423)∗ | 1.207 (1.041–1.400)∗ |
| Diabetes | 0.923 (0.804–1.060) | 0.897 (0.760–1.058) |
| Hypertension | 0.981 (0.836–1.151) | 1.035 (0.844–1.268) |
| Chronic pulmonary disease | 0.954 (0.828–1.099) | 0.915 (0.778–1.075) |
| Renal disease | 0.864 (0.730–1.022) | 0.826 (0.674–1.012) |
| Other arrhythmia | 1.326 (1.160–1.517)∗ | 1.312 (1.142–1.507)∗ |
| Valvular disease | 1.367 (1.207–1.548)∗ | 1.426 (1.251–1.625)∗ |
| Cardiomyopathy | 1.182 (1.006–1.389)∗ | 1.202 (0.969–1.490) |
| Myocardial infarction | 1.248 (1.001–1.558)∗ | 1.248 (0.987–1.578) |
| Heart failure | 1.048 (0.920–1.194) | 0.894 (0.738–1.083) |
CCI = Charlson Comorbidity Index; CRT-D = cardiac resynchronization therapy with defibrillator; EPO = Exclusive Provider Organization; HMO = Health Maintenance Organization; ICD = implantable cardioverter-defibrillator; POS = Point of Service; PPO = Preferred Provider Organization; REF = reference.
∗
P < .05.